2025-12-04 - Analysis Report
Okay, here's a breakdown of the Chevron (CVX) data you provided, with analysis:

**0) Data Overview**

We're analyzing Chevron (CVX), an integrated oil and gas company, focusing on its recent performance, indicators, and future prospects. We'll compare it to the S&P 500 (VOO).

**1) Return Rate Comparison**

*   **Company Overview:** Chevron Corp is a multinational energy corporation involved in every facet of the oil and natural gas industries – including exploration and production; refining, marketing and transport; chemicals manufacturing and sales; and power generation.
*   **CVX Cumulative Return:** 36.81%
*   **VOO Cumulative Return:** 100.36%
*   **Divergence:**
    *   Current: -65.9
    *   Range: Max 65.0, Min -66.3
    *   Relative Divergence: 0.3

*   **Analysis:** Chevron has significantly underperformed the S&P 500 over the period represented by the cumulative returns. The negative divergence of -65.9 indicates a substantial difference in performance. The relative divergence of 0.3 suggests that Chevron's underperformance is near the minimum level observed in past data.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD    | Alpha    | Beta   | Cap(B)  |
|------------|---------|--------|----------|--------|---------|
| 2015-2017  | 33.0%   | 65.9%  | 5.0%     | 0.1    | 252.3   |
| 2016-2018  | 21.0%   | 71.9%  | 6.0%     | 0.2    | 219.2   |
| 2017-2019  | 3.0%    | 71.9%  | -19.0%   | 0.9    | 242.8   |
| 2018-2020  | -10.0%  | 79.6%  | -33.0%   | 0.7    | 170.2   |
| 2019-2021  | 22.0%   | 79.6%  | -25.0%   | 0.6    | 236.5   |
| 2020-2022  | 85.0%   | 83.2%  | 86.0%     | 0.3    | 361.7   |
| 2021-2023  | 49.0%   | 83.2%  | 47.0%     | 0.4    | 300.6   |
| 2022-2024  | -6.0%   | 83.2%  | -26.0%   | 0.2    | 291.9   |
| 2023-2025  | -45.0%  | 74.8%  | -110.0%  | 0.6    | 307.0   |

*   **CAGR (Compound Annual Growth Rate):** Shows inconsistent growth, with periods of high growth (2020-2022) and significant decline (2023-2025).
*   **MDD (Maximum Drawdown):** Consistently high, indicating significant potential losses.  It is in the 65-83% range.
*   **Alpha:** Varies significantly. Positive alpha indicates outperformance relative to its benchmark (risk-adjusted). The negative alpha values, especially the recent -110%, are concerning.
*   **Beta:** Generally low (0.1 - 0.9), suggesting lower volatility than the market.
*   **Cap(B) (Market Capitalization in Billions):** Shows fluctuations, reflecting the changing valuation of the company.

**2) Recent Stock Price Fluctuations**

*   **Close:** 152.345
*   **Last Market:** Price 152.27, Previous Close 150.25, Change 1.34
*   **5-day SMA:** 150.297
*   **20-day SMA:** 152.7083
*   **60-day SMA:** 154.5072

*   **Analysis:** The current price is slightly below the 20-day and 60-day Simple Moving Averages (SMAs), suggesting a short-term downward trend. However, the price closed higher than the previous day which may indicate a change of trend. The fact that the 5-day SMA is below the 20-day SMA is also a bearish signal.

**3) Indicators Analysis**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 41.32 (Neutral)
*   **PPO:** -0.1142 (Slightly Bearish)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (12 shares - Safe - MRI:0.80) Dividend_1.71 (Cash Ratio: 0% on 2025-11-18)
*   **Recent (20 days) relative divergence change:** -6.1 (Short-term decline)
*   **Expected Return (%):** 994.9% (Long-term)

*   **Analysis:**
    *   **MRI:** Despite the underperformance, the MRI suggests a high investment recommendation. This could be due to a long-term outlook or other factors not explicitly provided.
    *   **RSI:** The RSI is below 50, indicating slightly bearish momentum. It's not yet in oversold territory.
    *   **PPO:** The PPO being slightly negative suggests that price trends are downwards.
    *   **Hybrid Signal:** Confirms the buy indicator from MRI.
    *   **Relative Divergence:** The recent decline in relative divergence reinforces the short-term downward trend.
    *   **Expected Return:** The exceptionally high expected return is unusual and warrants further scrutiny. It may be based on specific assumptions or models.

**4) Recent News & Significant Events**

*   **Key Headlines:**
    *   Evaluating Chevron's actual performance.
    *   Edgestream Partners L.P. Boosts Stock Position in Chevron.
    *   Chevron's Cash Flows and PE Ratio after Capital Spending.
    *   Jim Cramer recommends Chevron.
    *   Chevron Lags Sector YTD.

*   **Analysis:**
    *   The news coverage is mixed.  Some articles focus on performance evaluation, while others highlight increased investment.
    *   The article regarding cash flows and PE ratio could provide insights into the company's financial health and valuation.
    *   The "Chevron Lags Sector YTD" headline suggests relative underperformance compared to its peers.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (~2.08)
*   **Target Price:** 172.38 (Avg), 204.00 (High), 124.00 (Low)
*   **Recent Rating Changes:** Not available

*   **Analysis:** Analysts generally have a positive outlook on Chevron, with a "Buy" consensus. The average target price is significantly higher than the current price, suggesting potential upside. The range of target prices is wide, indicating uncertainty among analysts.

**5) Recent Earnings Analysis**

| 날짜        | EPS  | 매출      |
|-------------|------|-----------|
| 2025-11-06  | 1.83 | 48.17 B$  |
| 2025-08-07  | 1.45 | 44.38 B$  |
| 2025-05-08  | 2.01 | 46.10 B$  |
| 2024-11-07  | 2.49 | 48.93 B$  |
| 2025-11-06  | 2.49 | 48.93 B$  |

*   **Analysis:** Recent EPS and revenue figures are fluctuating. Revenue is fairly consistent, but EPS has seen some variation. Note that the first and last rows are identical. Overall, there appears to be a slight downward trend in earnings compared to the previous year.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30  | $48.17B    | 31.12%        |
| 2025-06-30  | $44.38B    | 29.69%        |
| 2025-03-31  | $46.10B    | 29.00%        |
| 2024-12-31  | $48.33B    | 27.34%        |
| 2024-09-30  | $48.93B    | 29.15%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE    |
|--------------|------------|--------|
| 2025-09-30  | $189.84B   | 1.86%  |
| 2025-06-30  | $146.42B   | 1.70%  |
| 2025-03-31  | $149.24B   | 2.35%  |
| 2024-12-31  | $152.32B   | 2.13%  |
| 2024-09-30  | $156.20B   | 2.87%  |

*   **Analysis:**
    *   **Revenue:** Revenue is relatively stable across the quarters.
    *   **Profit Margin:** Profit margins are healthy and above 27% but show a slight upward trend.
    *   **Equity:** Equity shows a bit of fluctuation.
    *   **ROE:** ROE is relatively low, suggesting that the company is not generating significant returns on its equity.

**7) Comprehensive Analysis**

Chevron has underperformed the S&P 500 significantly, as evidenced by the negative divergence in cumulative returns. While analyst consensus is "Buy" with a higher target price, recent performance indicators paint a mixed picture.

**Key Observations:**

*   **Underperformance:** The primary concern is the significant underperformance relative to the S&P 500.
*   **Inconsistent Growth:**  CAGR varies significantly, with recent periods showing negative growth.
*   **High Drawdown:** Consistently high MDD values highlight the potential for significant losses.
*   **Mixed Signals:**  The MRI suggests a high investment recommendation, while technical indicators (RSI, PPO) and divergence trends indicate short-term weakness.
*   **Analyst Optimism:**  Analysts maintain a positive outlook, with a "Buy" consensus and higher target price.
*   **Earnings Fluctuation:** Recent earnings figures are inconsistent.
*   **Financial Health:** Profit margins are strong, but ROE is relatively low.

**Overall Conclusion:**

Investing in Chevron carries both risks and potential rewards. The underperformance and negative trends need to be carefully considered. The analyst optimism and the MRI's high investment recommendation suggest that there may be long-term potential. However, further research and due diligence are recommended before making an investment decision. Focus should be put on what caused such a high underperformance over the selected periods.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.